On March 31, 2020, the FDA issued a warning letter to NeuroXPF for selling products with unsupported claims that they can treat coronavirus (COVID-19).
The company was promoting CBD products with statements such as "Crush Corona... There's something you can do right now to strengthen your immune system. Take CBD... CBD can help keep your immune system at the stop of its game... We want everyone to take CBD and take advantage of its potential to help prepare your body to fight a coronavirus infection."
The agency instructed the companies to send an email to COVID-19-Task-Force-CDER@fda.hhs.gov within 48 hours of receipt of the warning, describing the specific steps they have taken to correct these violations.
See ConsumerLab's CBD and Hemp Oil Review for information about CBD and COVID-19 and our tests of related products.
For other Recalls and Warnings click HERE.For information about reporting serious reactions and problems with medical products to the U.S. Food and Drug Administration through its MedWatch reporting program, please go to http://www.fda.gov/medwatch/how.htm.
Sign up for FREE Newsletter
BECOME A MEMBER
Instant Access to Reviews for OVER 1,000 Products!